We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Next Science Limited (ASX:NXS), an innovative medical technology company, announced that it will exhibit at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting and conference in...
Highlights Clinical trial for XPERIENCE commences after receiving FDA clearance in April Randomized, controlled, double-blinded study will evaluate the effects of XPERIENCE in decreasing surgical...
“The Balancing Act” segment will highlight how Next Science’s BLASTX® non-toxic, antimicrobial wound gel can help heal diabetic ulcers Next Science (ASX:NXS), an innovative medical technology...
Highlights XPERIENCE No Rinse Antimicrobial Solution receives FDA clearance XPERIENCE meets large unmet need – market leading performance in reduction of all tested pathogens Commercial sales in...
Highlights XPERIENCE No Rinse Antimicrobial Solution receives FDA clearance XPERIENCE meets large unmet need – market leading performance in reduction of all tested pathogens Commercial sales in...
New BlastX donation reaffirms the company’s commitment to healthcare nonprofits and their patients suffering from chronic wounds Next Science (ASX:NXS), an innovative medical technology company...
Blast X donation is one of several to long-term care facilities to effectively treat chronic wounds Next Science (ASX:NXS), an innovative medical technology company that is the leader in...
Woodside Petroleum Ltd. (WPL.AU) has lost its third senior staffer since it changed chief executives last year, with the head of its flagship Pluto gas-export project Lucio Della Martina leaving...
Nexus Energy Ltd. (NXS.AU) on Wednesday said several large companies have expressed interest in buying part of its share of the Crux gas and liquids joint venture with Royal Dutch Shell PLC (RDSB...
Nexus Energy Ltd. (NXS.AU) is poised to sell down a stake in its Crux liquids project offshore Western Australia state by next month ahead of officially approving construction of the A$1.78...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.005 | -3.57142857143 | 0.14 | 0.145 | 0.135 | 137188 | 0.13892995 | DE |
4 | -0.005 | -3.57142857143 | 0.14 | 0.17 | 0.13 | 209889 | 0.14385555 | DE |
12 | -0.085 | -38.6363636364 | 0.22 | 0.25 | 0.115 | 201203 | 0.15154831 | DE |
26 | -0.11 | -44.8979591837 | 0.245 | 0.305 | 0.115 | 173915 | 0.1946658 | DE |
52 | -0.145 | -51.7857142857 | 0.28 | 0.5 | 0.115 | 163668 | 0.25177418 | DE |
156 | -1.14 | -89.4117647059 | 1.275 | 1.33 | 0.115 | 136265 | 0.46069376 | DE |
260 | -2.375 | -94.6215139442 | 2.51 | 2.76 | 0.115 | 154573 | 0.95185665 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions